Stay updated on Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Sign up to get notified when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.

Latest updates to the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe footer now identifies the site software as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe navigation item was changed from 'Find Contact Information' to 'Find contact information'. The history log reflects a minor version update with Revision: v3.7.0 added and Revision: v3.6.6 removed.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study record history now shows a new revision entry, v3.6.6, superseding v3.6.5. It represents an update to the record metadata rather than substantive changes to the trial details.SummaryDifference0.1%

- Check77 days agoChange DetectedA new site revision entry, v3.6.5, has been added to the record history, while the previous revision v3.6.4 was removed. This reflects an update to the page's underlying release notes and software version.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, replacing the previous revision (v3.6.3). This indicates an update to the study record metadata on the page.SummaryDifference0.1%

Stay in the know with updates to Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intradermal IMO-2125 in T3-4 Melanoma Clinical Trial page.